Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Mayr, C; Speicher, MR; Kofler, DM; Buhmann, R; Strehl, J; Busch, R; Hallek, M; Wendtner, CM.
Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia.
Blood. 2006; 107(2):742-751
Doi: 10.1182/blood-2005-05-2093
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Co-authors Med Uni Graz
- Speicher Michael
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- In chronic lymphocytic leukemia (CLL), chromosomes usually evade detailed cytogenetic analyses because cells poorly respond to the traditionally used set of mitogens. We applied novel technologies, such as stimulation of CLL cells either with CD40 ligand or with a combination of CpG-oligodeoxynucleotides and IL-2, to increase the frequency of metaphase spreads for detailed chromosome analysis in 96 patients with CLL. This approach revealed that translocations occurred in 33 of 96 (34%) of our patients with CLL. The presence of translocations defined a new prognostic subgroup because these patients have significantly shorter median treatment-free survival (24 months vs 106 months; P < .001) and significantly inferior overall survival (OS; median, 94 months) than patients without translocations (346 months; P < .001). In multivariate analysis-including Binet stage, complex karyotype, CD38 expression, and 17p deletions-translocation proved to be the prognostic marker with the highest impact for an unfavorable clinical outcome (P < .001). In summary, we identified a new subgroup of patients with CLL defined by chromosomal trans-locations and poor prognosis. Our data may facilitate the identification of molecular events crucial for transforming activity in this disease and should have implications for risk-adapted clinical management of patients with CLL.
- Find related publications in this database (using NLM MeSH Indexing)
- Adult -
- Aged -
- Aged, 80 and over -
- Antigens, CD38 - metabolism
- Antineoplastic Agents - pharmacology
- CD40 Ligand - pharmacology
- Chromosomes, Human, Pair 17 - genetics
- Female - genetics
- Gene Deletion - genetics
- Humans - genetics
- In Situ Hybridization, Fluorescence - genetics
- Interleukin-2 - pharmacology
- Leukemia, Lymphocytic, Chronic - genetics
- Male - genetics
- Membrane Glycoproteins - metabolism
- Metaphase - metabolism
- Middle Aged - metabolism
- Oligodeoxyribonucleotides - pharmacology
- Prognosis - pharmacology
- Survival Rate - pharmacology
- Translocation, Genetic - pharmacology
- Tumor Cells, Cultured - pharmacology